跳至主要内容
临床试验/EUCTR2011-002144-27-NL
EUCTR2011-002144-27-NL进行中(未招募)不适用

A Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Study Comparing the Safety and Analgesic Efficacy of ABT-110 to Placebo in Subjects with Pain from Osteoarthritis of the Knee

Abbott GmbH & Co. KG0 个研究点目标入组 390 人开始时间: 2011年10月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
390

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Subject is between 18 and 70 years of age, inclusive.
  • 2. Osteoarthritis pain in the index knee which meets the following:
  • ? History of pain in the index knee = 6 months; AND
  • ? K-L Grade 2 or 3 only on plain radiographs of the index knee; AND
  • ? At least 1 of the following 3 criteria:
  • ? Age > 50 years; OR
  • ? Stiffness < 30 minutes upon awakening; OR
  • ? Crepitus in the index knee.
  • 3. Subject must meet the following pain criteria at the time of the Baseline Visit:
  • ? Subject's Assessment of Arthritis Pain Intensity (VAS) of the index knee is = 40 mm with an increase of = 10 mm from the Screening Visit,
  • o For subjects whose Screening VAS is = 85 mm, a VAS of = 85 mm must be maintained at the Baseline Visit; AND
  • ? Subject's Global Assessment of Arthritis Status must be Fair, Poor or Very Poor.
  • 4. Subject requires therapeutic doses of at least 1 non-opioid analgesic for OA pain for at least 4 days per week during the 4 weeks prior to the Screening Visit.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 310
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 80

排除标准

  • 1. Subject is scheduled for or is considering joint replacement surgery within 6 months following the Screening Visit.
  • 2. Subject has had any of the following:
  • ? Joint replacement/reconstruction to the index joint at any time;
  • ? Any major surgery, e.g., open surgery, to the index joint within 12 months
  • prior to the Screening Visit; OR
  • ? Arthroscopic surgery to the index joint within 3 months prior to the Screening
  • 3. Subject has a history of osteonecrosis in any joint.
  • 4. Subject has OA of the knee that meets the K-L classification criteria of grade 0, 1

研究者

相似试验

进行中(未招募)
不适用
A Study Comparing the Safety and Analgesic Efficacy of ABT-110 inSubjects with Pain from Osteoarthritis of the Knee
EUCTR2011-002144-27-PLAbbVie Deutschland GmbH & Co. KG350
进行中(未招募)
不适用
A Study Comparing the Safety and Analgesic Efficacy of ABT-110 inSubjects with Pain from Osteoarthritis of the KneePain from Osteoarthritis of the KneeMedDRA version: 15.1Level: LLTClassification code 10031165Term: Osteoarthritis kneeSystem Organ Class: 100000004859
EUCTR2011-002144-27-FIAbbVie Deutschland GmbH & Co. KG330
进行中(未招募)
不适用
A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects with Diabetic Neuropathic Pai
EUCTR2010-024359-99-DEAbbott GmbH & Co. KG180
进行中(未招募)
不适用
A Study Comparing the Safety and Analgesic Efficacy of ABT-110 in Subjects with Pain from Osteoarthritis of the KneePain from Osteoarthritis of the KneeMedDRA version: 14.1Level: LLTClassification code 10031165Term: Osteoarthritis kneeSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2011-002144-27-ITABBOTT GMBH & Co. KG390
进行中(未招募)
不适用
A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects with Diabetic Neuropathic PaiDiabetic Neuropathic PainMedDRA version: 14.0Level: LLTClassification code 10067547Term: Diabetic peripheral neuropathic painSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2010-024359-99-CZAbbott GmbH & Co. KG180